ValitaCell is part of an innovative consortium called AutoCRAT which aims to revolutionise the production of stem cell therapeutics. We are looking forward to working with the AutoCRAT team in the development of our Quantum & ChemStress platforms for cell manufacturing
The Regenerative Medicine Institute (Remedi) at NUI Galway will lead a €7.45m EU-backed research programme called AutoCRAT, will look to develop advanced cellular therapeutics for osteoarthritis and other major diseases. Read the full press release on Silicon Republic here.